文献速递肾小球疾病遗传性与小管间质肾病

Pkhd1与Pkd1协同遗传互作导致小鼠ARPKD样表型

Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.
PubMed 文献 · J Am Soc Nephrol · 2019-08-19

研究通过构建Pkhd1与Pkd1双基因突变小鼠和大鼠模型,发现两者存在剂量依赖的协同遗传互作,双基因动物出现快速进展性多囊肾病和早期致死,类似经典ARPKD。Pkhd1缺失不影响多囊蛋白表达与定位,但双基因模型初级纤毛调控异常增强,提示联合蛋白阈值触发协同囊性反应。

要点

  • Pkhd1与Pkd1双基因突变呈协同效应,导致快速进展性PKD和早期死亡。
  • 遗传互作依赖剂量,需突破第二基因座表达降低阈值才显著增强表型。
  • 纤毛 compartment 是共同失调靶点,双基因模型纤毛表达和长度改变增强。

核心结论

  • FPC与多囊蛋白独立工作,各有独立致病阈值,但联合蛋白阈值触发协同囊性反应。

研究设计与样本

  • 生成Pkhd1与Pkd1双基因小鼠和大鼠模型,比较双基因、单基因和野生型表型。

主要发现

  • 双基因动物表现快速进展性PKD和早期致死,类似经典ARPKD。
  • 遗传互作依赖剂量,未突破第二基因座表达降低阈值时单基因表型无显著增强。
  • Pkhd1缺失不改变ADPKD多囊蛋白的表达、成熟或定位。
  • 未检测到ARPKD FPC蛋白与多囊蛋白之间的相互作用。
  • RNA-seq显示双基因和单基因小鼠模型中纤毛 compartment 为共同失调靶点。

临床怎么用

  • 提示联合蛋白阈值和初级纤毛失调可能作为共同治疗靶点。

局限性

  • 研究基于小鼠和大鼠模型,结论外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autosomal recessive polycystic kidney disease (ARPKD) and autosomal dominant polycystic kidney disease (ADPKD) are genetically distinct, with ADPKD usually caused by the genes PKD1 or PKD2 (encoding polycystin-1 and polycystin-2, respectively) and ARPKD caused by PKHD1 (encoding fibrocystin/polyductin [FPC]). Primary cilia have been considered central to PKD pathogenesis due to protein localization and common cystic phenotypes in syndromic ciliopathies, but their relevance is questioned in the simple PKDs. ARPKD's mild phenotype in murine models versus in humans has hampered investigating its pathogenesis. METHODS: To study the interaction between Pkhd1 and Pkd1, including dosage effects on the phenotype, we generated digenic mouse and rat models and characterized and compared digenic, monogenic, and wild-type phenotypes. RESULTS: The genetic interaction was synergistic in both species, with digenic animals exhibiting phenotypes of rapidly progressive PKD and early lethality resembling classic ARPKD. Genetic interaction between Pkhd1 and Pkd1 depended on dosage in the digenic murine models, with no significant enhancement of the monogenic phenotype until a threshold of reduced expression at the second locus was breached. Pkhd1 loss did not alter expression, maturation, or localization of the ADPKD polycystin proteins, with no interaction detected between the ARPKD FPC protein and polycystins. RNA-seq analysis in the digenic and monogenic mouse models highlighted the ciliary compartment as a common dysregulated target, with enhanced ciliary expression and length changes in the digenic models. CONCLUSIONS: These data indicate that FPC and the polycystins work independently, with separate disease-causing thresholds; however, a combined protein threshold triggers the synergistic, cystogenic response because of enhanced dysregulation of primary cilia. These insights into pathogenesis highlight possible common therapeutic targets.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Olson RJ, Hopp K, Wells H, et al. Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models. J Am Soc Nephrol. 2019. PMID: 31427367. doi:10.1681/ASN.2019020150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。